Terns Pharmaceuticals, Inc. Current Liabilities
Terns Pharmaceuticals, Inc. had Current Liabilities of $16.41 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-03-30
- 2025-12-31: Liabilities, Current $16.41M.
- 2025-09-30: Liabilities, Current $15.39M.
- 2025-06-30: Liabilities, Current $12.91M.
- 2025-03-31: Liabilities, Current $10.94M.
| Period end | Liabilities, Current |
|---|---|
| 2025-12-31 | $16.41M 10-K · filed 2026-03-30 |
| 2025-09-30 | $15.39M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $12.91M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $10.94M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $15.65M 10-K · filed 2026-03-30 |
| 2024-09-30 | $11.41M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $10.96M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $8.83M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $11.94M 10-K · filed 2025-03-20 |
| 2023-09-30 | $12.09M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $14.24M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $12.11M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $8.47M 10-K · filed 2024-03-14 |
| 2022-09-30 | $7.48M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $6.04M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $6.17M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $6.82M 10-K · filed 2023-03-27 |
| 2021-09-30 | $6.89M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $5.82M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $8.38M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $22.82M 10-K · filed 2022-03-07 |